Toronto Dominion Bank Buys 10,682 Shares of The Allstate Co. (NYSE:ALL)

Toronto Dominion Bank grew its position in shares of The Allstate Co. (NYSE:ALL - Free Report) by 8.2% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 141,580 shares of the insurance provider's stock after buying an additional 10,682 shares during the period. Toronto Dominion Bank owned approximately 0.05% of Allstate worth $27,295,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors also recently modified their holdings of the company. Park Avenue Securities LLC raised its stake in Allstate by 40.8% in the 4th quarter. Park Avenue Securities LLC now owns 10,184 shares of the insurance provider's stock worth $1,963,000 after purchasing an additional 2,951 shares in the last quarter. Carnegie Investment Counsel increased its holdings in shares of Allstate by 116.9% during the fourth quarter. Carnegie Investment Counsel now owns 2,562 shares of the insurance provider's stock worth $494,000 after purchasing an additional 1,381 shares during the period. Wealthcare Advisory Partners LLC raised its position in shares of Allstate by 30.5% in the fourth quarter. Wealthcare Advisory Partners LLC now owns 1,456 shares of the insurance provider's stock valued at $281,000 after buying an additional 340 shares in the last quarter. Merit Financial Group LLC boosted its stake in shares of Allstate by 78.9% in the fourth quarter. Merit Financial Group LLC now owns 3,909 shares of the insurance provider's stock valued at $754,000 after buying an additional 1,724 shares during the period. Finally, Premier Path Wealth Partners LLC grew its position in Allstate by 4.7% during the fourth quarter. Premier Path Wealth Partners LLC now owns 2,480 shares of the insurance provider's stock worth $478,000 after buying an additional 112 shares in the last quarter. Institutional investors and hedge funds own 76.47% of the company's stock.

Allstate Price Performance

ALL stock traded down $2.87 during midday trading on Thursday, reaching $202.44. 1,179,990 shares of the stock were exchanged, compared to its average volume of 1,612,798. The Allstate Co. has a 52 week low of $156.66 and a 52 week high of $212.91. The company has a fifty day moving average price of $199.78 and a 200 day moving average price of $196.08. The company has a debt-to-equity ratio of 0.42, a current ratio of 0.36 and a quick ratio of 0.40. The stock has a market capitalization of $53.61 billion, a PE ratio of 11.92, a P/E/G ratio of 1.01 and a beta of 0.32.

Allstate (NYSE:ALL - Get Free Report) last released its quarterly earnings results on Wednesday, April 30th. The insurance provider reported $3.53 earnings per share for the quarter, missing the consensus estimate of $3.98 by ($0.45). Allstate had a return on equity of 28.20% and a net margin of 7.28%. The firm had revenue of $14.30 billion for the quarter, compared to the consensus estimate of $16.41 billion. During the same quarter last year, the firm posted $5.13 earnings per share. The business's revenue for the quarter was up 7.8% on a year-over-year basis. As a group, analysts expect that The Allstate Co. will post 18.74 EPS for the current fiscal year.

Allstate Increases Dividend

The firm also recently announced a quarterly dividend, which was paid on Tuesday, April 1st. Shareholders of record on Monday, March 10th were issued a dividend of $1.00 per share. This represents a $4.00 dividend on an annualized basis and a yield of 1.98%. This is a positive change from Allstate's previous quarterly dividend of $0.92. The ex-dividend date was Monday, March 10th. Allstate's payout ratio is presently 27.32%.

Allstate declared that its Board of Directors has approved a share repurchase program on Wednesday, February 26th that allows the company to buyback $1.50 billion in outstanding shares. This buyback authorization allows the insurance provider to reacquire up to 3% of its stock through open market purchases. Stock buyback programs are usually an indication that the company's board believes its shares are undervalued.

Wall Street Analyst Weigh In

Several equities analysts have weighed in on ALL shares. JPMorgan Chase & Co. lifted their price objective on Allstate from $217.00 to $222.00 and gave the company an "overweight" rating in a report on Tuesday, April 8th. Barclays dropped their price target on Allstate from $183.00 to $172.00 and set an "underweight" rating for the company in a research note on Friday, April 11th. Wells Fargo & Company reduced their price objective on shares of Allstate from $200.00 to $197.00 and set an "equal weight" rating on the stock in a research note on Tuesday, May 6th. Evercore ISI boosted their target price on shares of Allstate from $227.00 to $230.00 and gave the company an "outperform" rating in a research report on Thursday, May 1st. Finally, Keefe, Bruyette & Woods lifted their price objective on shares of Allstate from $228.00 to $235.00 and gave the company an "outperform" rating in a research note on Wednesday, May 7th. One analyst has rated the stock with a sell rating, one has issued a hold rating, fourteen have issued a buy rating and one has given a strong buy rating to the company's stock. Based on data from MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and a consensus target price of $225.20.

Allstate Profile

The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.